주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 17:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
41 )
기사목록 보기 형태
제목형
요약형
포토형
Enhertu moves closer to insurance coverage by passing drug-reimbursing panel
Kim Yun-mi
2024.02.02 13:26
‘If you seek natural beauty, the choice is clear: CaHA’
Kim Yun-mi
2023.12.22 15:48
Tagrisso, Leclaza get reimbursement for 1st-line NSCLC treatment
Kim Yun-mi
2023.12.21 13:58
What’s the scientific evidence for regenerative aesthetics?
Kim Yun-mi
2023.12.21 13:48
Why Merz Aesthetics is fully committed to medical aesthetics
Kim Yun-mi
2023.12.20 11:01
Besremi shows efficacy in Korean patients with polycythemia vera
Kim Yun-mi
2023.12.19 11:01
‘Reimbursing Padcev is urgent to treat severe urothelial cancer with no alternative treatments’
Kim Yun-mi
2023.12.18 13:10
‘SGLT-2 inhibitors are not optional but compulsory for chronic kidney disease patients’
Kim Yun-mi
2023.11.29 13:44
Patients on edge as drug price bargaining for Braftovi prolongs
Kim Yun-mi
2023.11.28 14:17
How should the government reimburse Covid-19 treatments without harming patients?
Kim Yun-mi
2023.11.27 16:09
Will Piqray end up as ill-fated breast cancer drug in Korea?
Kim Yun-mi
2023.11.24 13:31
What impact will Keytruda have on treating advanced gastric cancer?
Kim Yun-mi
2023.11.14 18:15
처음
이전
이전
1
2
3
4
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기